Half Moon Bay, CA, United States of America

Brian M Fendly

This inventor holds 15 USPTO granted patents and 5 published patent applications and 1 EPO patent. Top assignees: Genentech, Inc., Genetech, Inc.. Active years: 1997-2008.

USPTO Granted Patents = 15 (Patent Applications = 5)

% Patents Active = 100.0

EPO Patents = 1 (Patent Applications = 2)

Average Co-Inventor Count = 3.2

ph-index = 12

Forward Citations = 1,916(Granted Patents)

Company Filing History:

Years Active: 1997-2008

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7371376 - Anti-ErbB2 antibodies (2008-05-13),

2. 7041293 - HIV env antibodies (2006-05-09),

3. 6737249 - Agonist antibodies (2004-05-18),

4. 6399063 - Monoclonal antibodies directed to the HER2 receptor (2002-06-04),

5. 6387371 - Monoclonal antibodies directed to the HER2 receptor (2002-05-14),

6. 6342220 - Agonist antibodies (2002-01-29),

7. 6165464 - Monoclonal antibodies directed to the HER2 receptor (2000-12-26),

8. 5849533 - Method for making unclipped HIV envelope protein (1998-12-15),

9. 5772997 - Monoclonal antibodies directed to the HER2 receptor (1998-06-30),

10. 5770195 - Monoclonal antibodies directed to the her2 receptor (1998-06-23),

11. 5725856 - Monoclonal antibodies directed to the HER2 receptor (1998-03-10),

12. 5720954 - Monoclonal antibodies directed to the HER2 receptor (1998-02-24),

13. 5720937 - In vivo tumor detection assay (1998-02-24),

14. 5677171 - Monoclonal antibodies directed to the HER2 receptor (1997-10-14),

15. 5674984 - Method for isolation of unclipped HIV envelope protein (1997-10-07),

Sure, here is an article about inventor Brian M Fendly:

**Title: The Innovative Journey of Brian M Fendly**

Introduction:

Brian M Fendly, a talented inventor based in Half Moon Bay, CA, has made significant contributions to the field of biotechnology. With an impressive portfolio of 15 patents to his name, Fendly has been a trailblazer in the development of novel antibodies with diverse applications.

Latest Patents:

1. **Anti-ErbB2 antibodies:** Fendly's pioneering work includes the creation of Anti-ErbB2 antibodies that target a specific epitope in Domain 1 of ErbB2, showcasing the ability to induce cell death via apoptosis. These antibodies have shown promising uses in various applications.

2. **HIV env antibodies:** His innovative invention of HIV env antibodies, including monoclonal antibodies and related hybridomas, has proven to be a breakthrough. These antibodies exhibit specificity for HIV env, effectively blocking CD4/g120 binding and reducing reverse transcriptase activity in vitro.

Career Highlights:

Brian M Fendly is associated with Genentech, Inc., a renowned biotechnology company known for its groundbreaking research and development initiatives. His affiliation with Genentech underscores his dedication to driving innovation and making a lasting impact in the biotech industry.

Collaborations:

Fendly has had the privilege of collaborating with esteemed professionals in the field, such as Robert M Hudziak and Axel Ullrich. These collaborations have not only enriched his work but have also led to the successful implementation of cutting-edge technologies in his inventions.

Conclusion:

In conclusion, Brian M Fendly's exceptional work as an inventor and his relentless pursuit of innovation have solidified his position as a visionary in the realm of biotechnology. His patents stand as a testament to his ingenuity and unwavering commitment to advancing scientific knowledge for the betterment of society.